PharmACT AG

PharmACT is a Germany-based company that specializes in creating solutions that provide early detection of diseases. It was founded in 2014 and has several locations throughout Germany and the United States.

PharmACT offers several diagnostic and medical products to detect and prevent the spread of disease. The company focuses on developing, manufacturing, and distributing diagnostics for multiple types of diseases.

PharmACT also developed a respiratory protection mask to mitigate the spread of infectious diseases that are spread through the air. The device consists of a mask, filters, a harness, a blower, and a charger. It was intended to be used by medical professionals as they faced COVID-19 patients daily during the first few waves of the COVID-19 pandemic.

In 2020, PharmACT developed a rapid COVID-19 test for home use so users testing positive could presumably quarantine and not spread the virus. PharmACT partnered with several other healthcare and pharmaceutical companies during the early days of the COVID-19 pandemic to develop the rapid tests. Partnerships included Vivera Pharmaceuticals, and the two companies released a rapid test to diagnose COVID-19 in March 2020.